EANM Alavi-Carlsen Award

EANM Alavi-Carlsen Award

At the beginning of 2026, EANM proudly launched the EANM Alavi-Carlsen Award, made possible through the generous support of Prof. Abass Alavi!

Aim:

The Alavi-Carlsen Award recognises outstanding publications in one of the two EANM journals by young professionals under the age of 38 at the time of publication.

Eligibility:

• The research must be published in one of the EANM journals (The EANM Journal or EANM Innovation) in the calendar year before the award is granted.
• The first or corresponding author must be a nuclear medicine scientist younger than 38 years at the time of publication.
• Only original research articles are eligible (reviews, guidelines, position papers, editorials, or “hotspot” articles are excluded).

Prize:

For each journal, one prize of €4,000 will be awarded. The prize must be used for scientific development or training within institutions in Europe.

Process:

When submitting their research to the EANM journals, authors will have the option to indicate their interest in being considered for the award directly in the Editorial Manager system.

A dedicated jury of EANM experts, including the Editors-in-Chief of the EANM journals, will evaluate all eligible submissions. Two winners will be selected each year – one per journal.

The winners will be presented at the EANM’26 congress.

The story behind the award:

The EANM Alavi-Carlsen Award was established to honour two leading figures in nuclear medicine, Abass Alavi and Poul Flemming Høilund-Carlsen, while supporting the next generation of researchers in the field.

A pioneer in molecular imaging, Abass Alavi played a key role in the development of FDG PET imaging and helped transform the diagnosis of cancer, neurological and cardiovascular diseases. Throughout his career, he has also strongly supported young scientists and innovation in medical imaging. His long-time collaborator Poul Flemming Høilund-Carlsen has likewise made major contributions to PET/CT imaging and to the clinical interpretation of imaging biomarkers, helping shape modern nuclear medicine research and practice.

Together, their work and international collaboration have had a lasting impact on the field. Established through Alavi’s generous support, the award celebrates this legacy while encouraging young researchers to continue advancing nuclear medicine. You can find out more about Abass Alavi and Poul Flemming Høilund-Carlsen here.

Questions:

For any questions about the award, feel free to contact us at editorial.office@eanm.org.